Results 171 to 177 of about 3,675 (177)

Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal

ACS Infectious Diseases, 2020
Anne-Marie W Turner, Raghuvar Dronamraju, Frances Potjewyd   +2 more
exaly  

Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo

Journal of Virology, 2018
Carolina Garrido, Marina Tuyishime, Guido Ferrari   +2 more
exaly  

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV

Cell Reports Medicine, 2020
Matthew D Marsden, Tian-Hao Zhang, Yushen Du   +2 more
exaly  

Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1

EBioMedicine, 2019
Tatiana M Garcia-Bates, Nicolas Sluis-Cremer, Phalguni Gupta   +2 more
exaly  

The mTOR Complex Controls HIV Latency

Cell Host and Microbe, 2016
Emilie Besnard, Martin Kampmann, Nina N Hosmane   +2 more
exaly  

Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal

Cell Chemical Biology, 2018
Mateusz Stoszko, Elisa De Crignis, Jovylyn Gatchalian   +2 more
exaly  

Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets

Antimicrobial Agents and Chemotherapy
Ellen Van Gulck, Brigitte Allard, Jennifer Kirchherr   +2 more
exaly